Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Cell ; 29(13): 1682-1692, 2018 07 15.
Article in English | MEDLINE | ID: mdl-29791254

ABSTRACT

Tetraploid cells, which are most commonly generated by errors in cell division, are genomically unstable and have been shown to promote tumorigenesis. Recent genomic studies have estimated that ∼40% of all solid tumors have undergone a genome-doubling event during their evolution, suggesting a significant role for tetraploidy in driving the development of human cancers. To safeguard against the deleterious effects of tetraploidy, nontransformed cells that fail mitosis and become tetraploid activate both the Hippo and p53 tumor suppressor pathways to restrain further proliferation. Tetraploid cells must therefore overcome these antiproliferative barriers to ultimately drive tumor development. However, the genetic routes through which spontaneously arising tetraploid cells adapt to regain proliferative capacity remain poorly characterized. Here, we conducted a comprehensive gain-of-function genome-wide screen to identify microRNAs (miRNAs) that are sufficient to promote the proliferation of tetraploid cells. Our screen identified 23 miRNAs whose overexpression significantly promotes tetraploid proliferation. The vast majority of these miRNAs facilitate tetraploid growth by enhancing mitogenic signaling pathways (e.g., miR-191-3p); however, we also identified several miRNAs that impair the p53/p21 pathway (e.g., miR-523-3p), and a single miRNA (miR-24-3p) that potently inactivates the Hippo pathway via down-regulation of the tumor suppressor gene NF2. Collectively, our data reveal several avenues through which tetraploid cells may regain the proliferative capacity necessary to drive tumorigenesis.


Subject(s)
Genetic Testing , MicroRNAs/genetics , Tetraploidy , Adaptor Proteins, Signal Transducing/metabolism , Cell Proliferation/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Down-Regulation/genetics , Humans , MicroRNAs/metabolism , Mitogens/metabolism , Neurofibromin 2/metabolism , Phosphoproteins/metabolism , Signal Transduction , Transcription Factors , Tumor Suppressor Protein p53/metabolism , YAP-Signaling Proteins
2.
Pharmacol Biochem Behav ; 157: 1-8, 2017 06.
Article in English | MEDLINE | ID: mdl-28408289

ABSTRACT

Changes in the expression of the dopamine transporter (DAT), or the sensitivity of dopamine receptors, are associated with aging and substance abuse and may underlie some of the symptoms common to both conditions. In this study, we explored the role of the dopaminergic system in the anxiogenic effects of aging and acute cocaine exposure by comparing the behavioral phenotypes of wild type (WT) and DAT knockout zebrafish (DAT-KO) of different ages. To determine the involvement of specific dopamine receptors in anxiety states, antagonists to D1 (SCH23390) and D2/D3 (sulpiride) were employed. We established that DAT-KO results in a chronic anxiety-like state, seen as an increase in bottom-dwelling and thigmotaxis. Similar effects were produced by aging and acute cocaine administration, both leading to reduction in DAT mRNA abundance (qPCR). Inhibition of D1 activity counteracted the anxiety-like effects associated with DAT deficit, independent of its origin. Inhibition of D2/D3 receptors reduced anxiety in young DAT-KO, and enhanced the anxiogenic effects of cocaine in WT, but did not affect aged WT or DAT-KO fish. These findings provide new evidence that the dopaminergic system plays a critical role in anxiety-like states, and suggest that adult zebrafish provide a sensitive diurnal vertebrate model for elucidating the molecular mechanisms of anxiety and a platform for anxiolytic drug screens.


Subject(s)
Aging/metabolism , Anxiety/metabolism , Dopamine Plasma Membrane Transport Proteins/deficiency , Dopamine/deficiency , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism , Aging/drug effects , Aging/genetics , Animals , Animals, Genetically Modified , Anxiety/genetics , Base Sequence , Dopamine/genetics , Dopamine Antagonists/pharmacology , Dopamine Plasma Membrane Transport Proteins/genetics , Male , Receptors, Dopamine D1/genetics , Receptors, Dopamine D2/genetics , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...